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Abstract— This study aims to employ in vivo dynamic 
contrast-enhanced magnetic resonance imaging (DCE-MRI) to 
evaluate the ocular transport following an induction of ocular 
hypertension in a rat model of chronic glaucoma. Upon systemic 
administration of Gd-DTPA solution, T1-weighted signal 
increase was observed in the vitreous body of the glaucomatous 
eye but not the control eye. This increase occurred earlier in the 
anterior vitreous body than the preretinal vitreous. Further, there was 
an earlier Gd-DTPA transport into the anterior chamber in the 
majority of glaucomatous eyes. Our DCE-MRI findings revealed the 
leakage of Gd-DTPA at the aqueous-vitreous interface, which was 
likely resulted from increased permeability of blood-aqueous or 
aqueous-vitreous barrier. These may explain the sources of 
changing biochemical compositions in the chamber components, 
which may implicate the neurodegenerative processes in the 
glaucomatous visual components.  
I. INTRODUCTION 
LAUCOMA is a neurodegenerative disease of the 
visual system characterized by an increase in intraocular 
pressure (IOP). It is the second major cause of 
blindness in the world [1]. While the level of IOP is 
governed by the dynamic balance between aqueous humor 
formation and drainage [2], the elevated IOP in primary 
open-angle glaucoma (POAG) is believed to arise due to an 
increased resistance to the outflow of aqueous humor from 
the eye [3]. Nevertheless, due to the lack of a non-invasive 
method to monitor the inner-depth of the eye without 
critically affecting the dynamic behavior of the aqueous 
outflow system, the aqueous outflow obstructions in  
glaucoma have not been well understood [4]. 
MRI allows inner-depth localization of dynamic ocular 
processes in vivo. Recent studies using the arterial spin 
labeling technique showed high basal blood flows in the 
ciliary body and retina of rat eyes [5]. In the ciliary body, the 
aqueous humor is produced primarily by active transport 
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across epithelial cells lining the surface of the ciliary 
processes [6], and is drained away from the venous plexus of 
the limbus via a circumferential Schlemm’s canal into 
multiple radial veins located within the episclera [2]. This 
conventional route of aqueous humor outflow [7] taken by 
plasma-derived proteins has been traced using dynamic 
contrast-enhanced magnetic resonance imaging (DCE-MRI) 
[8], by demonstrating the entrance of an exogenous MR 
contrast agent Gd-DTPA from the bloodstream into the 
ciliary body stroma, and its exit via the iris root [9]. This 
potentiated the study of changes in aqueous flow in the rat 
model of chronic glaucoma using DCE-MRI. 
Despite the relatively small molecular mass of Gd-
DTPA (938 Da), in normal intact eyes, the blood-retinal 
barrier and aqueous-vitreous barrier are impermeable to Gd-
DTPA [10, 11]. DCE-MRI has been used to examine the 
pathology that altered the permeability of blood-aqueous 
barrier [9, 12] and blood-retinal barrier [11, 13] in both 
human and animal eyes. On the basis of the previous findings 
about the potential roles of blood-ocular [14-16] and 
aqueous-vitreous barrier integrity [17-19] in the pathogenesis 
of POAG, this study aims to employ high resolution DCE-
MRI to understand the aqueous humor dynamics following 
an induction of ocular hypertension in a rat model of chronic 
glaucoma. We hypothesized that systemic administration of 
Gd-DTPA into our glaucoma model would detect whether 
leakage existed at the aqueous-vitreous interface giving rise 
to a progressive signal enhancement in the anterior vitreous 
body of the glaucomatous eye. Further, we attempted to 
monitor the transport of Gd-DTPA into the anterior chamber 
of our glaucoma model. Such transport phenomena may help 
understand the sources of biochemicals present in the 
chamber components of the glaucomatous eye, which may 
have participated in the neurodegenerative processes in the 
retina and the optic nerve [20, 21].  
II. MATERIALS AND METHODS 
A. Animal Preparation 
Sprague-Dawley female rats (250-280 g, 3 months old, 
N=11) were divided into two groups and were induced for 
ocular hypertension unilaterally in the right eye by 
photocoagulation of episcleral veins and the limbal veins on 
the surface of the eyeball using an argon laser. DCE-MRI 
was performed at Day 5 (Group 1, n=5) and Week 8 (Group 
2, n=6) after laser treatment to maintain a consistent IOP 
elevation by about 1.6 times above the normal level. This 
technique was modified from the method by WoldeMussie et 
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al [22] and has been adopted in our laboratory for the study 
of retinal degeneration and therapeutic effects on retinal 
functions [20, 21, 23, 24]. After each procedure, antibiotic 
ointment was applied topically to the eye surface. 
B. MRI Protocols  
All MRI measurements were acquired on a 7T Bruker 
scanner using a birdcage transmit-only RF coil in 
combination with an actively decoupled receive-only 
quadrature surface coil. Under inhaled isoflurane anaesthesia 
(3% induction and 1.5% maintenance), the animal was kept 
warm under circulating water at 37 oC. A saline phantom was 
inserted beside the rat for signal intensity normalization 
during post-processing. Five days (Group 1) and 8 weeks 
(Group 2) after laser treatment, Gd-DTPA (Magnevist) was 
applied intraperitoneally at 3 mmol/kg, and 2D fast spin echo 
(FSE) T1-weighted imaging (T1WI) was acquired with fat 
suppression, TR/TE = 320/8.9 ms, echo train length = 4, 
NEX = 26, slice thickness = 1 mm, FOV = 3.2 x 3.2 cm2 and 
voxel resolution = 82.3 x 82.3 µm2. Acquisition time was 10 
minutes for each time point, and T1WI was applied before 
and 10 to 80 minutes after injection. Throughout the 
experiments, the left eye served as a control. Between 0 and 
10 minutes after injection, T1WI was also acquired in Group 
1 with the same T1WI protocol above but with NEX = 5 and 
acquisition time = 2 min for each time point to monitor the 
enhanced pattern immediately after injection. 
C. Data Analysis 
 
 
Fig. 1.  Illustration of the typical ROI definitions of the anterior chamber 
(AC) and vitreous body (VB) to quantify the DCE-MRI measurements. The 
lens (Ln) and optic nerves (ON) could be observed as hypointense signals 
in both pre- (left) and post- (right) systemic Gd-DTPA injection images, 
while the hyperintense ciliary processes could be found between the 
posterior chamber (PC) and VB after systemic Gd-DTPA injection (right). 
 
In the 2D slice that centrally cut through the eyeball and 
optic nerve head, regions of interest (ROIs) were drawn 
manually on the whole anterior chamber, and on the vitreous 
body covering a distance of 3.5 mm on each side from the 
optic nerve head using ImageJ v1.38 (Wayne Rasband, NIH, 
USA) as shown in Figure 1. Each value was calibrated to the 
nearby phantom containing saline solution to avoid the effect 
of any MRI system sensitivity drift. A quantitative measure 
of the Gd-DTPA entry was obtained from the enhancement 
in the MR signal intensity defined as E = [S(t) – So]/So, 
where S(t) is the calibrated spin-echo signal intensity of the 
ROIs, and So is the T1-weighted signal intensity of the same 
ROI before the MR tracer injection. Differences between 
mean values of the ROIs on both sides were compared using 
two-tailed paired t-tests, and the mean values along the time 
course were compared using ANOVA. Results were 
considered to be significantly different when p<0.05. 
III. RESULTS 
 
 
Fig. 2.  Serial T1-weighted images (T1WIs) of a rat at Day 5 (Group 1) after 
glaucoma induction. Images were acquired within the first 10 minutes 
following systemic Gd-DTPA administration. Note that in 3 out of the 5 
rats in the group, the intensity in the anterior chamber was greater for the 
glaucomatous eye (R) (arrow) than the control one (L) in the first 10 
minutes after systemic Gd-DTPA administration.  
 
Figures 2 and 3 show the serial T1WIs of the 
glaucomatous and control eyes after systemic Gd-DTPA 
administration. Figure 4 shows the mean percent signal 
enhancement, E, as a function of the time for the vitreous 
body in both eyes. In the control eye, there was an immediate 
enhancement of the ciliary processes, iris and chorioretina in 
all scanned rats after Gd-DTPA administration (Figure 2). 
The anterior chamber enhanced substantially over the first 
40-60 minutes after Gd-DTPA administration (ANOVA, 
p<0.01), while the vitreous and lens did not enhance at any 
time (ANOVA, p>0.05) (Figure 3). These patterns of T1-
weighted signal enhancements generally followed as 
previously described [8-10, 25] and were of consistent or 
better spatial and temporal resolutions. 
Similar patterns appeared in the glaucomatous eye. 
However, the vitreous body enhanced progressively from 10 
minutes post-administration in both groups after glaucoma 
induction (Figures 3 and 4) (ANOVA, p<0.01). Significant 
difference was observed between the glaucomatous and the 
control eyes in Group 2 (paired t-test, p<0.05), and was 
marginally observed in Group 1 (paired t-test, p <0.07 for 
the later 2 time points). No apparent difference was observed 
between the two groups on the signal changes in the 
glaucomatous eyes (unpaired t-test, p>0.05). Qualitative 
inspection of the MR images of both groups suggested that 
Gd-DTPA leaked at the aqueous-vitreous interface and 
diffused into the vitreous body from the anterior parts of the 
glaucomatous eye in all rats, while no apparent signal 
increase was observed in the same location in the control 
eyes (Figure 3). Note that in 3 out of the 5 rats in Group 1, 
the intensity in the anterior chamber is greater for the 
glaucomatous eye than the control one in the first 10 minutes 
after Gd-DTPA administration (Figure 2). For Group 2, 4 
out of 6 rats had their signal intensities higher in the 
glaucomatous anterior chamber than the control throughout 
the experiment.  
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Fig. 3.  Windowed and zoomed serial T1WIs of the Week 8 (Group 2) 
glaucomatous (a) and control (b) eyeballs 10 to 80 minutes following 
systemic Gd-DTPA administration. The corresponding un-windowed image 
at 80 minutes post-administration was also shown on top to illustrate the 
regions of interest for zooming. Different extents of leakiness from the 
aqueous-vitreous interface (arrows) into the vitreous body were visible in 
the glaucomatous eye but not the control eye as time went by. 
 
 
 
Fig. 4.  Time course of T1W signal enhancement of the vitreous body of 
both eyes before and at 10-80 minutes following Gd-DTPA administration 
into both groups. The vitreous body did not enhance in the control eye, yet 
there was a progressive increase in signal intensity in the glaucomatous eye. 
(ANOVA across timeline in glaucomatous (g) and control (c) eyes with 
#p<0.01). No apparent difference between the two groups was observed in 
the signal changes in the glaucomatous or control eye. 
IV. DISCUSSIONS 
In the present study we characterized the aqueous humor 
dynamics in a rat model of chronic glaucoma. Obstruction of 
aqueous humor outflow is the primary mechanism of 
pressure elevation in the current glaucoma model [26] 
analogous to the pathogenesis of human POAG [27]. Our 
DCE-MRI results showed an alteration of the typical 
aqueous outflow in the glaucomatous eye that might explain 
the changing biochemical compositions in the anterior 
chamber and vitreous body [15, 16, 19].  
The aqueous humor proteins have been identified as 
suspected participants in the obstruction of the aqueous 
humor outflow network from the eye resulting in elevated 
IOP in POAG [27]. Protein concentration in the anterior 
chamber of normal eyes has been identified to be determined 
by the rate of protein entry into the aqueous humor, the 
removal rate by bulk flow of aqueous humor, and the 
anterior chamber volume [28]. Our results of increased Gd-
DTPA level in the anterior chamber appeared to correlate 
with the breakdown of blood-aqueous barrier in various 
glaucoma which resulted in an increase in the aqueous 
protein level upon the presence of cytokines and other 
inflammatory mediators in the aqueous humor [9, 12] 
including vascular endothelial growth factor [16] and 
endothelin-1 [15].  
On the other hand, the earlier T1-weighted signal increase 
in the anterior vitreous body indicated the leakage of Gd-
DTPA at the aqueous-vitreous interface upon aqueous 
outflow obstruction. A recent study had commented on the 
impact of IOP on the induction of the hydraulic flow 
permeating through the vitreous body [18]. When the IOP 
was increased in the current glaucoma model, it was likely 
that this anteriorly directed fluid movement across the 
aqueous-vitreous interface would be reduced [29]. In 
addition, in response to prolonged IOP elevation, the ciliary 
epithelium which prevents the aqueous humor proteins from 
entering the posterior chamber by its tight junctions [27], has 
been shown to undergo atrophy in canine [30]. Iris atrophy 
was also observed in a transgenic glaucoma model [31]. The 
reduced limitation of back-diffusion of solutes might 
attribute to the posterior transport of Gd-DTPA from the 
anterior chamber to the vitreous body. Note that the pattern 
of leakage of proteins from the blood supply in the ciliary 
body/iris complex has been postulated in experimental 
newborn rats, when the tight junctions of the blood-ocular 
barriers were underdeveloped [32]. 
In one of the glaucomatous eyes in Group 2, a faster 
leakage into the vitreous body was observed compared to the 
other diseased eyes of the same group, while a prominent 
lens depression was also noted (Figure 5). Upon perfusion of 
the anterior chamber at elevated pressures, the iris and the 
detached portion of the ciliary body were pushed backwards 
[17]. A significant increase in the number of giant vacuoles 
was also found in the endothelium of several blood vessels in 
the rat ciliary body and the iris root [7]. These might also 
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contribute to the compromise of the aqueous-vitreous barrier 
integrity, allowing Gd-DTPA to pass into the vitreous body. 
Our results potentially explained the routes for the leakage of 
serum proteins as well as the release of proteolytic enzymes 
into the rat vitreous body upon chronic intraocular 
hypertension [19]. DCE-MRI was also performed at Week 
18 on three of the Group 2 animals scanned, and similar 
pattern of Gd-DTPA leakage was observed as in Groups 1 
and 2 (data not shown). No statistical difference was 
observed in the signal changes in the glaucomatous eyes 
between two groups, which was in agreement with the fact 
that a consistent IOP elevation of 1.6 times above normal 
was maintained in our model across the 8-week experimental 
period [21]. Further studies may employ multi-compartment 
modeling for more comprehensive kinetics analyses in the 
future. 
 
 
 
Fig. 5.  Leakage of Gd-DTPA into the vitreous body appeared faster in one 
of the 6 glaucomatous eyes in Group 2. A prominent lens depression was 
observed at the same time along the direction pointed by the arrow. 
V. CONCLUSIONS 
The results presented here constitute the first report in 
assessing the leakage at the aqueous-vitreous interface upon 
ocular hypertension by DCE-MRI. A progressive T1-
weighed signal increase was observed in the vitreous body of 
the glaucomatous eye but not the control eye, while an 
earlier Gd-DTPA transport was found in the anterior 
chamber of the glaucomatous eye. The authors demonstrated 
the values of MRI in providing a means for direct non-
invasive visualization of physiological kinetics in the 
glaucomatous chamber components in vivo. 
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